speb/financial-data huggingface dataset:
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income: 709302000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 709302000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 708089000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 709302000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 709302000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 708089000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -59592000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -59592000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1391315000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 758658768.41
POLYMED.NS income_statement (quarterly, 2025-12-31) — Operating Income: -743496000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4936555000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 262634000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1055510000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 976125000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3125374000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 287558000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Research And Development: 59582000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -68040000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -18683231.59
POLYMED.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 268036000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
POLYMED.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 5680051000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -68040000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -68040000.00
POLYMED.NS income_statement (annual, 2026-03-31) — +Operating Expense: 9516481000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2841842000.00
POLYMED.NS income_statement (annual, 2026-03-31) — +Total Revenue: 18752592000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 5345114000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1226651000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1226651000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 5311727000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5311727000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 191987000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 191987000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 99451070.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 6.54
POLYMED.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 86988000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3083919000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 119584000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 119584000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 506797000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 506797000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 512282000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 512282000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8725271000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8725271000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -354310000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -371881000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -361563000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 11594000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Payable: 122241000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -993104000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -1489174000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 411449000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Common Stock: 506797000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 506797000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 31061727000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 31061727000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 3378000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 905137000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 905137000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 5968112000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1781619000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Assets: 19417332000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 19417332000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 67973000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 67973000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Debt: 2895298000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 2895298000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2963271000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2963271000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 5755224000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5755224000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 25603000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 25603000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Depreciation: 1155166000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1155166000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1155166000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 382320000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1155166000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 382320000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 99603369.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 6.53
POLYMED.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 650410000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 40206000.00
POLYMED.NS income_statement (annual, 2026-03-31) — EBIT: 4457618000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — EBIT: 916308000.00
POLYMED.NS income_statement (annual, 2026-03-31) — EBITDA: 5612784000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1298628000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — End Cash Position: 512282000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 201514000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -620173000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -536964000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 2205000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Goodwill: 2737871000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2737871000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 4390833000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4390833000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 13536211000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 13536211000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Gross Profit: 12784480000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3563495000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Interest Expense: 182907000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 64086000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 182907000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 64086000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -159932000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 138185000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Inventory: 4338407000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 4338407000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 34477902000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 34477902000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2253811000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 191987000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 191987000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 3378000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 51611000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 51611000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 520877000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 520877000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 572488000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 572488000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 151779000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 151779000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 310670000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 310670000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 430705000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 430705000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -3860265000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 3378000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2903893000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2903893000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 26198000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income: 650410000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 650410000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 650410000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 650410000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 650410000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 4274711000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 3312921000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 650410000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Interest Income: -182907000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -64086000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 4817749000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 745677000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 745677000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -182907000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -64086000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -331600000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Net PPE: 13536211000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 13536211000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3058086000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 26670894000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 26670894000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 15758000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 15758000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 736426000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 736426000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 579690000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 579690000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 5680824000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1298628000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Normalized Income: 3365652317.94
POLYMED.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 650410000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2463746000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Operating Income: 3267999000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Operating Income: 721653000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Operating Revenue: 18752592000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 5345114000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 101359490.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 101359490.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 13845000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1034484000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1034484000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 564295000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 564295000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 30554930000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 30554930000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1652962000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1652962000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -336040000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 761104000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 761104000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 100075000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 100075000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1200822000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 177565000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4039997000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1130683000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Properties: 12631074000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 12631074000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 7443000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 7443000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 8212989000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 8212989000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Payables: 1312647000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1312647000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 74088000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Pretax Income: 4274711000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 852222000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 15214000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -3860265000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3083919000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 5968112000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1781619000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1155166000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 382320000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Research And Development: 298759000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Research And Development: 67429000.00
POLYMED.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 25833000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Share Issued: 101359490.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 101359490.00
POLYMED.NS income_statement (annual, 2026-03-31) — Special Income Charges: -68040000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 31061727000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 31061727000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 26670894000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 26670894000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -15308682.06
POLYMED.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
POLYMED.NS income_statement (annual, 2026-03-31) — Tax Provision: 961790000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 201812000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.22
POLYMED.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
POLYMED.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1017442000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Assets: 39185672000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 39185672000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 31582604000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 31582604000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Debt: 3535759000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 3535759000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 31492432000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 31492432000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Total Expenses: 15484593000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4623461000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 7693240000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7693240000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 19768340000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 19768340000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1938016000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1938016000.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 85996000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 85996000.00
POLYMED.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -68040000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
POLYMED.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -68040000.00
POLYMED.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
POLYMED.NS balance_sheet (annual, 2026-03-31) — Working Capital: 13662108000.00
POLYMED.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 13662108000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -29654509000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1159738000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2881000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Amortization: 11329000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1042000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 11805370000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 2903251000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 5140567000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 563938000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 20770000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 64537000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 319000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 5664370000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 472890000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 11038812000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 10995000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 1390000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Interest Income: 196202000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 196202000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1878772000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 47060360000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Net Debt: 1352258000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -132000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 38242000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 3703700000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 2300000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 179626000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 134038000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 351000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Other Payable: 211674000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 224173000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Other Special Charges: -116000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 32679000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1610102000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -132000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 5305844000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 155842000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 155842000.00
POLYPLEX.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 65742000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 24472808000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 5469938000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 5942828000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Special Income Charges: -3304000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 44700000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 17546000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -34344000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -34344000.00
POLYPLEX.NS balance_sheet (annual, 2022-03-31) — Work In Process: 2114929000.00
POLYPLEX.NS income_statement (annual, 2022-03-31) — Write Off: 2030000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — +Operating Expense: 14317116000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — +Total Revenue: 76402885000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4653035000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9214692000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -33891044000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1159738000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -14034000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 861000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1425595000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 31391628.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Basic EPS: 110.97
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 8043818000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 12918662000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2728952000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 121738000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 319711000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 9645452000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 10975872000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -3234880000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 4918956000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 4726496000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -736407000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -368917000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -779676000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Payable: -439945000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 1740539000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -557190000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 296131000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Common Stock: 319711000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -3234880000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 34829453000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3021294000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 55484049000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Assets: 36599632000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 30844000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Debt: 4135671000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 4166515000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 123248000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 11106080000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 33200000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Depreciation: 2961977000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2962838000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2962838000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2962838000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 14608000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 31391628.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Diluted EPS: 110.97
POLYPLEX.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 3483529000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 157397000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — EBIT: 7428653000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — EBITDA: 10391491000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 1305503000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — End Cash Position: 9645452000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -6569617000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 5021779000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 5286071000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -10658000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -2733000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 620885000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Goodwill: 2928000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 3799000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9228726000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 69398817000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Gross Profit: 20918836000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 29269000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 5812000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Interest Expense: 320483000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 320483000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Interest Income: 234820000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 234820000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -352786000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 225873000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Inventory: 13629402000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 42697786000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1149275000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 27679000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1425595000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 20980000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2010011000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 90894000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 3732662000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 3823556000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 20980000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1510305000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 230600000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 50954886000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 22863438000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Minority Interests: -2671854000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 122634000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income: 3483529000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 3483529000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 6155383000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 3483529000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 3483529000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 7108170000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 6155383000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -609000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Interest Income: -117834000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 1323893000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1983216000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -1489325000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -117834000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1303400000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Net PPE: 35507773000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -2698432000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -493891000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 34825654000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1981000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 236765000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1096640000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 230593000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 165465000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 10026557000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Normalized Income: 3167496156.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 8015023000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Operating Income: 6601720000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Operating Revenue: 76402885000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 31392462.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 21327000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 88571000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 25080000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 871000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 80660000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1077800000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1348000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 114115000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1004646000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Payable: 506830000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Properties: 493964000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 372495000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1330420000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Other Special Charges: -383681000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Payables: 5317262000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 33187000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 2201735000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Pretax Income: 7108170000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 11584000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -609000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -10605864000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -2728343000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 5850230000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 55542113000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2962838000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 173093000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 173093000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1510305000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 154840000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 24579477000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 11929757000.00
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 29911000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 4804845000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 5425730000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Share Issued: 31392462.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Special Income Charges: 376344000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 34829453000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 34825654000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 48901156.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Tax Provision: 952787000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.13
POLYPLEX.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1898242000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Assets: 73967697000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 38562115000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Debt: 7990071000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 57692891000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Total Expenses: 69801165000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 16274806000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 37368065000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5168726000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 32171000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 123300000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 364934000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 364934000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Work In Process: 2757393000.00
POLYPLEX.NS balance_sheet (annual, 2023-03-31) — Working Capital: 25493552000.00
POLYPLEX.NS income_statement (annual, 2023-03-31) — Write Off: 1525000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — +Operating Expense: 13180059000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — +Total Revenue: 62943875000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 5381097000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 9712737000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -36097613000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1159738000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -9379000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Amortization: 431000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 431000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 2897510000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 31392462.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Basic EPS: 12.05
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 9645452000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 12928345000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -5171562000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 197355000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 319711000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 4632972000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 8018371000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -252214000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 3043261000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1589711000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -120318000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 138114000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 204784000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Payable: 872630000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -470283000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 648963000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -4933717000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Common Stock: 319711000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -252214000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 35111307000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 6999305000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 48242727000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Assets: 33745230000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 59967000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3737394000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3797361000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 11555000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 11363356000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 34374000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Depreciation: 3071288000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3071288000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 3071288000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 3070857000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 0.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 31392462.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Diluted EPS: 12.05
POLYPLEX.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 378316000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 62003000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — EBIT: 1151277000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — EBITDA: 4222565000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -78763000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — End Cash Position: 4632972000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1522112000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 5620078000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -619323000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 27816000.00
POLYPLEX.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 5581000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 791202000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Goodwill: 2540000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2824000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 9722116000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 73072413000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Gross Profit: 14701148000.00
POLYPLEX.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 4644000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 25000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Interest Expense: 392167000.00
POLYPLEX.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 392167000.00